Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

References for PMC Articles for PubMed (Select 20501655)

1.

LRP1 regulates remodeling of the extracellular matrix by fibroblasts.

Gaultier A, Hollister M, Reynolds I, Hsieh EH, Gonias SL.

Matrix Biol. 2010 Jan;29(1):22-30. doi: 10.1016/j.matbio.2009.08.003. Epub 2009 Aug 20.

2.

Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited.

Sabeh F, Shimizu-Hirota R, Weiss SJ.

J Cell Biol. 2009 Apr 6;185(1):11-9. doi: 10.1083/jcb.200807195. Epub 2009 Mar 30.

3.

The urokinase receptor as an entertainer of signal transduction.

D'Alessio S, Blasi F.

Front Biosci (Landmark Ed). 2009 Jan 1;14:4575-87. Review.

PMID:
19273372
4.

Computer aided identification of small molecules disrupting uPAR/alpha5beta1--integrin interaction: a new paradigm for metastasis prevention.

Chaurasia P, Mezei M, Zhou MM, Ossowski L.

PLoS One. 2009;4(2):e4617. doi: 10.1371/journal.pone.0004617. Epub 2009 Feb 26.

5.

Integrins and cell-fate determination.

Streuli CH.

J Cell Sci. 2009 Jan 15;122(Pt 2):171-7. doi: 10.1242/jcs.018945. Review.

6.

Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression.

Kogianni G, Walker MM, Waxman J, Sturge J.

Eur J Cancer. 2009 Mar;45(4):685-93. doi: 10.1016/j.ejca.2008.11.023. Epub 2008 Dec 26.

PMID:
19112015
7.

Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins.

Tang CH, Hill ML, Brumwell AN, Chapman HA, Wei Y.

J Cell Sci. 2008 Nov 15;121(Pt 22):3747-56. doi: 10.1242/jcs.029769. Epub 2008 Oct 21.

8.

Urokinase plasminogen activator receptor choreographs multiple ligand interactions: implications for tumor progression and therapy.

Mazar AP.

Clin Cancer Res. 2008 Sep 15;14(18):5649-55. doi: 10.1158/1078-0432.CCR-07-4863. Review.

9.

uPAR mediates anticancer activity of PEDF.

Dass CR, Choong PF.

Cancer Biol Ther. 2008 Aug;7(8):1262-70. Epub 2008 Aug 10.

10.

Peptides and small molecules targeting the plasminogen activation system: towards prophylactic anti-metastasis drugs for breast cancer.

Tyndall JD, Kelso MJ, Clingan P, Ranson M.

Recent Pat Anticancer Drug Discov. 2008 Jan;3(1):1-13. Review.

PMID:
18289119
11.

Evolving role of uPA/uPAR system in human cancers.

Dass K, Ahmad A, Azmi AS, Sarkar SH, Sarkar FH.

Cancer Treat Rev. 2008 Apr;34(2):122-36. Epub 2007 Dec 26. Review.

PMID:
18162327
12.

Clustal W and Clustal X version 2.0.

Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG.

Bioinformatics. 2007 Nov 1;23(21):2947-8. Epub 2007 Sep 10.

13.

Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.

He Y, Liu XD, Chen ZY, Zhu J, Xiong Y, Li K, Dong JH, Li X.

Clin Cancer Res. 2007 Jun 1;13(11):3115-24.

14.

Antibody engineering and modification technologies.

Filpula D.

Biomol Eng. 2007 Jun;24(2):201-15. Epub 2007 Mar 31. Review.

PMID:
17466589
15.

Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells.

Wei Y, Tang CH, Kim Y, Robillard L, Zhang F, Kugler MC, Chapman HA.

J Biol Chem. 2007 Feb 9;282(6):3929-39. Epub 2006 Dec 4.

16.

A cancer cell metalloprotease triad regulates the basement membrane transmigration program.

Hotary K, Li XY, Allen E, Stevens SL, Weiss SJ.

Genes Dev. 2006 Oct 1;20(19):2673-86. Epub 2006 Sep 18. Erratum in: Genes Dev. 2007 May 1;21(9):1139.

17.

Targeting proteases: successes, failures and future prospects.

Turk B.

Nat Rev Drug Discov. 2006 Sep;5(9):785-99. Review.

PMID:
16955069
18.

The urokinase receptor: a ligand or a receptor? Story of a sociable molecule.

Ragno P.

Cell Mol Life Sci. 2006 May;63(9):1028-37. Review.

PMID:
16465446
19.

Plasminogen activation and cancer.

Danø K, Behrendt N, Høyer-Hansen G, Johnsen M, Lund LR, Ploug M, Rømer J.

Thromb Haemost. 2005 Apr;93(4):676-81. Review.

PMID:
15841311
20.

The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis.

Alfano D, Franco P, Vocca I, Gambi N, Pisa V, Mancini A, Caputi M, Carriero MV, Iaccarino I, Stoppelli MP.

Thromb Haemost. 2005 Feb;93(2):205-11. Review.

PMID:
15711734
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk